Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (Text with EEA relevance.)

• CELEX: Implementing Regulation (EU) 2019/1589
• Articles: 3

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by ‘31 October 2020’;

(2)

in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by ‘31 October 2020’;

(3)

in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2020’;

(4)

in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by ‘31 October 2020’;

(5)

in the sixth column, expiration of approval, of row 102, Chlorotoluron, the date is replaced by ‘31 October 2020’;

(6)

in the sixth column, expiration of approval, of row 103, Cypermethrin, the date is replaced by ‘31 October 2020’;

(7)

in the sixth column, expiration of approval, of row 104, Daminozide, the date is replaced by ‘31 October 2020’;

(8)

in the sixth column, expiration of approval, of row 105, Thiophanate-methyl, the date is replaced by ‘31 October 2020’;

(9)

in the sixth column, expiration of approval, of row 107, MCPA, the date is replaced by ‘31 October 2020’;

(10)

in the sixth column, expiration of approval, of row 108, MCPB, the date is replaced by ‘31 October 2020’;

(11)

in the sixth column, expiration of approval, of row 119, Indoxacarb, the date is replaced by ‘31 October 2020’;

(12)

in the sixth column, expiration of approval, of row 160, Prosulfocarb, the date is replaced by ‘31 October 2020’;

(13)

in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘31 October 2020’;

(14)

in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘31 October 2020’;

(15)

in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘31 December 2020’;

(16)

in the sixth column, expiration of approval, of row 170, Nicosulfuron, the date is replaced by ‘31 December 2020’;

(17)

in the sixth column, expiration of approval, of row 171, Clofentezine, the date is replaced by ‘31 December 2020’;

(18)

in the sixth column, expiration of approval, of row 172, Dicamba, the date is replaced by ‘31 December 2020’;

(19)

in the sixth column, expiration of approval, of row 173, Difenoconazole, the date is replaced by ‘31 December 2020’;

(20)

in the sixth column, expiration of approval, of row 174, Diflubenzuron, the date is replaced by ‘31 December 2020’;

(21)

in the sixth column, expiration of approval, of row 176, Lenacil, the date is replaced by ‘31 December 2020’;

(22)

in the sixth column, expiration of approval, of row 178, Picloram, the date is replaced by ‘31 December 2020’;

(23)

in the sixth column, expiration of approval, of row 179, Pyriproxyfen, the date is replaced by ‘31 December 2020’;

(24)

in the sixth column, expiration of approval, of row 180, Bifenox, the date is replaced by ‘31 December 2020’;

(25)

in the sixth column, expiration of approval, of row 181, Diflufenican, the date is replaced by ‘31 December 2020’;

(26)

in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘31 December 2020’;

(27)

in the sixth column, expiration of approval, of row 183, Fenpropidin, the date is replaced by ‘31 December 2020’;

(28)

in the sixth column, expiration of approval, of row 186, Tritosulfuron, the date is replaced by ‘30 November 2020’;

(29)

in the sixth column, expiration of approval, of row 289, Triflusulfuron, the date is replaced by ‘31 December 2020’.